Intrapleural BCG in operable lung cancer

Lancet. 1980 Jan 5;1(8158):11-4. doi: 10.1016/s0140-6736(80)90551-6.

Abstract

In a controlled randomised clinical trial of 92 patients with surgically resected lung cancer, intrapleural BCG had no clear effect on survival. Adverse effects were insignificant.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adenocarcinoma / surgery
  • Adenocarcinoma / therapy
  • Adenocarcinoma, Bronchiolo-Alveolar / surgery
  • Adenocarcinoma, Bronchiolo-Alveolar / therapy
  • BCG Vaccine / administration & dosage*
  • BCG Vaccine / therapeutic use
  • Carcinoma, Small Cell / surgery
  • Carcinoma, Small Cell / therapy
  • Carcinoma, Squamous Cell / surgery
  • Carcinoma, Squamous Cell / therapy
  • Follow-Up Studies
  • Humans
  • Lung Neoplasms / mortality
  • Lung Neoplasms / surgery
  • Lung Neoplasms / therapy*
  • Neoplasm Staging
  • Pleura
  • Postoperative Care

Substances

  • BCG Vaccine